NPCE
NeuroPace, Inc. NASDAQ Listed Apr 22, 2021$15.37
Mkt Cap $502.9M
52w Low $8.25
64.5% of range
52w High $19.29
50d MA $16.26
200d MA $14.31
P/E (TTM)
-23.6x
EV/EBITDA
—
P/B
26.4x
Debt/Equity
3.7x
ROE
-112.8%
P/FCF
-44.4x
RSI (14)
36.30
ATR (14)
$0.73
Beta
1.88
50d MA
$16.26
200d MA
$14.31
Avg Volume
177.4K
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
CIK (SEC)
Phone
650 237 2700
455 North Bernardo Avenue · Mountain View, CA 94043 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | AMC | -0.14 | -0.08 | +42.9% | 13.83 | +12.7% | +0.9% | -2.5% | +3.2% | +0.1% | +1.2% | — |
| Nov 4, 2025 | AMC | -0.20 | -0.11 | +45.0% | 9.40 | +23.7% | +38.1% | -1.5% | +2.7% | +2.5% | +0.3% | — |
| Aug 12, 2025 | AMC | -0.24 | -0.26 | -8.3% | 9.13 | -2.0% | +2.1% | -3.1% | -5.2% | -1.6% | -2.0% | — |
| May 13, 2025 | AMC | -0.26 | -0.21 | +19.2% | 12.95 | +10.4% | +20.5% | +9.5% | +2.4% | -2.8% | +5.8% | — |
| Mar 4, 2025 | AMC | -0.25 | -0.18 | +28.0% | 11.92 | +6.1% | -2.4% | -3.9% | -1.6% | -8.7% | +3.2% | — |
| Nov 12, 2024 | AMC | -0.26 | -0.19 | +26.9% | 7.14 | +8.1% | +28.2% | +5.8% | -7.2% | -0.3% | +2.6% | — |
| Aug 13, 2024 | AMC | -0.29 | -0.26 | +10.3% | 7.28 | +0.3% | -7.0% | +4.9% | -3.2% | +3.3% | +2.0% | — |
| May 8, 2024 | AMC | -0.32 | -0.32 | +0.0% | 12.60 | -1.4% | -36.7% | +6.6% | +0.2% | -0.1% | +6.1% | — |
| Mar 5, 2024 | AMC | -0.33 | -0.23 | +30.3% | 14.20 | +0.7% | -1.5% | +1.1% | +0.6% | -4.4% | +0.5% | — |
| Nov 6, 2023 | AMC | -0.39 | -0.28 | +28.2% | 7.20 | -3.1% | -1.8% | +2.5% | +6.8% | +1.4% | +8.2% | — |
| Aug 8, 2023 | AMC | -0.47 | -0.36 | +23.4% | 4.10 | +6.1% | +9.8% | +0.0% | +0.0% | -0.7% | +0.7% | — |
| May 4, 2023 | AMC | -0.46 | -0.41 | +10.9% | 4.99 | +2.6% | -0.8% | +3.5% | -8.5% | +2.3% | -7.3% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 27 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.23 | $16.21 | -0.1% | -1.7% | -2.1% | -1.9% | -1.2% | +5.2% |
| Dec 16 | UBS | Maintains | Buy → Buy | — | $15.92 | $16.00 | +0.5% | -0.3% | -1.6% | +0.8% | +5.4% | -0.2% |
| Dec 10 | JP Morgan | Maintains | Overweight → Overweight | — | $16.27 | $16.74 | +2.9% | +3.1% | -1.8% | -1.8% | -1.7% | -0.3% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.40 | $11.63 | +23.7% | +38.1% | -1.5% | +2.7% | +2.5% | +0.3% |
| Nov 5 | JP Morgan | Maintains | Overweight → Overweight | — | $9.40 | $11.63 | +23.7% | +38.1% | -1.5% | +2.7% | +2.5% | +0.3% |
| Aug 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $9.13 | $8.95 | -2.0% | +2.1% | -3.1% | -5.2% | -1.6% | -2.0% |
| May 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $12.95 | $14.30 | +10.4% | +20.5% | +9.5% | +2.4% | -2.8% | +5.8% |
| May 14 | JP Morgan | Maintains | Overweight → Overweight | — | $12.95 | $14.30 | +10.4% | +20.5% | +9.5% | +2.4% | -2.8% | +5.8% |
| Apr 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $10.42 | $10.74 | +3.1% | +2.4% | -3.1% | +0.9% | +3.5% | -2.3% |
| Mar 5 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $11.92 | $12.65 | +6.1% | -2.4% | -3.9% | -1.6% | -8.7% | +3.2% |
| Jan 30 | Wells Fargo | Maintains | Overweight → Overweight | — | $14.69 | $14.99 | +2.0% | -3.4% | -3.0% | -1.1% | +2.1% | +2.8% |
| Dec 17 | JP Morgan | Maintains | Overweight → Overweight | — | $11.47 | $11.59 | +1.0% | +0.4% | -7.6% | +4.7% | +3.5% | -0.8% |
| Nov 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.14 | $7.72 | +8.1% | +28.2% | +5.8% | -7.2% | -0.3% | +2.6% |
| Aug 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $7.28 | $7.30 | +0.3% | -7.0% | +4.9% | -3.2% | +3.3% | +2.0% |
| Aug 14 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $7.28 | $7.30 | +0.3% | -7.0% | +4.9% | -3.2% | +3.3% | +2.0% |
| Jul 15 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $7.44 | $7.42 | -0.3% | +3.5% | +4.2% | -6.4% | -2.8% | +9.0% |
| May 9 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $12.60 | $12.42 | -1.4% | -36.7% | +6.6% | +0.2% | -0.1% | +6.1% |
| Mar 14 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $13.38 | $14.36 | +7.3% | +1.9% | -3.3% | -2.6% | +4.8% | +1.4% |
| Mar 12 | JP Morgan | Maintains | Overweight → Overweight | — | $13.60 | $13.92 | +2.4% | +0.5% | -2.1% | +1.9% | -3.3% | -2.6% |
| Mar 6 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $14.20 | $14.30 | +0.7% | -1.5% | +1.1% | +0.6% | -4.4% | +0.5% |
| Mar 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $14.20 | $14.30 | +0.7% | -1.5% | +1.1% | +0.6% | -4.4% | +0.5% |
| Feb 22 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $15.61 | $15.64 | +0.2% | -1.9% | +11.2% | -0.4% | +0.9% | -2.2% |
| Dec 27 | Lake Street | Maintains | Buy → Buy | — | $9.90 | $10.08 | +1.8% | +1.6% | -0.6% | +3.1% | -5.1% | +2.8% |
| Dec 4 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.90 | $8.85 | -0.6% | -8.7% | +2.2% | -1.1% | +3.3% | -1.1% |
| Nov 14 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $8.49 | $8.78 | +3.4% | -1.1% | +3.6% | +0.6% | -1.1% | +0.6% |
| Nov 7 | JP Morgan | Maintains | Overweight → Overweight | — | $7.20 | $6.98 | -3.1% | -1.8% | +2.5% | +6.8% | +1.4% | +8.2% |
| Oct 4 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $8.41 | $8.21 | -2.4% | -6.7% | +0.1% | +6.2% | -16.0% | +8.4% |
| Aug 24 | Morgan Stanley | Upgrade | Underweight → Equal Weight | — | $4.78 | $4.79 | +0.2% | +7.9% | +16.3% | +16.2% | +27.8% | -3.4% |
| May 5 | Morgan Stanley | Maintains | Underweight → Underweight | — | $4.99 | $5.12 | +2.6% | -0.8% | +3.5% | -8.5% | +2.3% | -7.3% |
| Mar 3 | Morgan Stanley | Maintains | Underweight → Underweight | — | $4.20 | $4.36 | +3.8% | -2.4% | +12.2% | -5.2% | -4.1% | +2.4% |
| Feb 22 | Lake Street | Maintains | Buy → Buy | — | $5.34 | $5.48 | +2.6% | -11.0% | +4.4% | +0.2% | +0.6% | +2.6% |
| Jan 6 | Morgan Stanley | Maintains | Underweight → Underweight | — | $1.53 | $1.62 | +5.5% | +2.9% | +3.2% | +35.6% | +6.3% | +12.8% |
| Oct 11 | Morgan Stanley | Maintains | Underweight → Underweight | — | $3.09 | $3.05 | -1.3% | +2.6% | -0.6% | +0.0% | +0.0% | +3.2% |
| Jul 15 | Morgan Stanley | Maintains | Underweight → Underweight | — | $5.73 | $5.81 | +1.4% | +0.2% | +0.7% | -1.9% | +2.1% | +0.2% |
| May 13 | Morgan Stanley | Maintains | Underweight → Underweight | — | $6.26 | $6.34 | +1.3% | -1.8% | -17.1% | +14.9% | -1.0% | +3.4% |
| May 13 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $6.26 | $6.34 | +1.3% | -1.8% | -17.1% | +14.9% | -1.0% | +3.4% |
| Apr 6 | Wolfe Research | Maintains | Outperform → Outperform | — | $8.44 | $9.00 | +6.6% | -0.8% | -0.2% | -3.6% | -2.0% | +5.8% |
| Mar 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $7.61 | $7.32 | -3.8% | +6.2% | +3.2% | -9.8% | +6.4% | +4.4% |
| Mar 11 | SVB Leerink | Maintains | Outperform → Outperform | — | $7.61 | $7.32 | -3.8% | +6.2% | +3.2% | -9.8% | +6.4% | +4.4% |
| Jan 19 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $10.04 | $9.20 | -8.4% | -3.0% | -3.4% | -1.6% | +0.3% | -0.2% |
| Jan 7 | Morgan Stanley | Downgrade | Equal Weight → Underweight | — | $11.57 | $10.41 | -10.0% | -13.2% | +0.0% | +6.7% | +7.2% | -5.9% |
| Aug 18 | Baird | Maintains | Outperform → Outperform | — | $19.85 | $19.81 | -0.2% | -3.1% | +1.3% | +0.1% | +4.4% | +0.4% |
| Jun 3 | SVB Leerink | Maintains | Outperform → Outperform | — | $22.49 | $22.76 | +1.2% | -3.6% | +4.6% | +4.0% | +3.8% | +1.3% |
| May 17 | Wells Fargo | Maintains | Overweight → Overweight | — | $20.91 | $20.85 | -0.3% | +3.9% | +15.6% | -6.2% | -3.5% | -0.3% |
| May 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $20.91 | $20.85 | -0.3% | +3.9% | +15.6% | -6.2% | -3.5% | -0.3% |
| May 17 | JP Morgan | Maintains | Overweight → Overweight | — | $20.91 | $20.85 | -0.3% | +3.9% | +15.6% | -6.2% | -3.5% | -0.3% |
| May 17 | SVB Leerink | Maintains | Outperform → Outperform | — | $20.91 | $20.85 | -0.3% | +3.9% | +15.6% | -6.2% | -3.5% | -0.3% |
No insider trades available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 5,095,568 | $79M | — | Dec 2025 |
| 2 | Soleus Capital Management, L.p. | 2,932,207 | $39M | Added | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 1,123,711 | $15M | New | Mar 2026 |
| 4 | Fmr Llc | 553,529 | $7M | Reduced | Mar 2026 |
| 5 | Northern Trust Corp | 239,840 | $3M | Added | Mar 2026 |
| 6 | Essex Investment Management Co Llc | 217,738 | $3M | Added | Mar 2026 |
| 7 | Palumbo Wealth Management Llc | 210,469 | $3M | Reduced | Mar 2026 |
| 8 | Vanguard Portfolio Management Llc | 187,429 | $2M | New | Mar 2026 |
| 9 | Qube Research & Technologies Ltd | 186,189 | $2M | Reduced | Mar 2026 |
| 10 | Algert Global Llc | 179,556 | $2M | Added | Mar 2026 |
| 11 | Russell Investments Group, Ltd. | 179,021 | $2M | Added | Mar 2026 |
| 12 | Renaissance Technologies Llc | 174,311 | $2M | Reduced | Mar 2026 |
| 13 | Point72 Asset Management | 152,025 | $2M | Added | Mar 2026 |
| 14 | Jane Street Group, Llc | 117,558 | $2M | New | Dec 2025 |
| 15 | Jpmorgan Chase & Co | 141,141 | $2M | Added | Mar 2026 |
| 16 | Tudor Investment Corp | 135,705 | $2M | New | Mar 2026 |
| 17 | Sei Investments Co | 121,476 | $2M | Added | Mar 2026 |
| 18 | Panagora Asset Management Inc | 114,275 | $2M | Added | Mar 2026 |
| 19 | Nuveen, Llc | 89,287 | $1M | Reduced | Mar 2026 |
| 20 | Citadel Advisors Llc | 87,284 | $1M | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$502.9M
Enterprise Value
$510.6M
P/E (TTM)
-23.58x
Forward P/E
—
PEG Ratio
0.81x
P/B
26.43x
P/S
5.05x
P/FCF
-44.36x
EV/EBITDA
—
Shares Out
32.7M
Financials (TTM)
Revenue
$99.5M
Net Income
-$21.6M
EBITDA
-$13.8M
Free Cash Flow
-$11.3M
Op Cash Flow
-$11.0M
EPS Basic
$-0.66
EPS Diluted
$-0.65
EPS Forward
$-0.61
Gross Margin
78.3%
Op Margin
-16.8%
Net Margin
-21.7%
Balance Sheet
Total Assets
$105.6M
Total Liab.
$86.5M
Total Equity
$19.0M
Cash
$61.1M
LT Debt
$68.7M
Book Value/Sh
$0.58
Debt/Equity
3.72x
Current Ratio
5.28
Quick Ratio
4.33
Returns & Growth
ROE
-112.8%
ROA
-20.3%
ROIC
-18.2%
Rev Growth YoY
+25.1%
EPS Growth YoY
+29.0%
Price Returns
2W
+4.7%
1M
-1.9%
3M
+13.4%
6M
+1.1%
12M
+25.1%
Technicals
52W High
$19.29
52W Low
$8.25
50d MA
$16.26
200d MA
$14.31
RSI (14)
36.30
ATR (14)
$0.73
Beta
1.88
Avg Volume
177K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$19.00
High
$22.00
Low
$16.00
Median
$19.00
Data updated apr 26, 2026 3:37pm
· Source: financialmodelingprep.com